Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

In this study, we applied NGS to this archived cohort, we aimed to determine whether significant differences exist in miRNA expression between these groups, ultimately identifying new miRNAs that are directly related to T2DM (glucose and HbA1C levels) or T2DM complications (vitamin D deficiency and platelet activation).

Source: Introduction. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Circulating microRNA signatures as potential biomarkers differentiating diabetic, prediabetic, and healthy individuals

Study design awaiting verification · Frontiers in Endocrinology · 2025

Original publication title

Circulating microRNA signatures as potential biomarkers differentiating diabetic, prediabetic, and healthy individuals

Hanifa J. Abu-Toamih Atamni; Guy Shapira; Rona Ortenberg; Maya Sultan; Orit Twito; Liat Yoseph-Barzilay; Noam Shomron; Gloria Rashid

Copyright © 2025 Abu-Toamih Atamni, Shapira, Ortenberg, Sultan, Twito, Yoseph-Barzilay, Shomron and Rashid.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: What background does the paper provide?

Circulating microRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and play key roles in metabolic diseases, including diabetes. This study aimed to identify circulating miRNA signatures linked to glycemic status, vitamin D deficiency, aspirin consumption, and platelet activity in individuals with type 2 diabetes, prediabetes, and healthy controls.

Source: Introduction

Abstract: What methods does the paper describe?

Plasma samples from 24 participants (14 with diabetes, 2 prediabetic, and 8 non-diabetic controls) were analyzed using next-generation sequencing to assess differences in miRNA expression.

Source: Methods

Abstract: Discussion

Collectively, these data highlight the exploratory potential of circulating miRNAs as candidate early biomarkers for glycemic dysregulation, providing a foundation for future validation and development of improved diagnostic and preventive strategies for type 2 diabetes.

Source: Discussion

Abstract: Results

Although principal component analysis showed no group separation, pairwise testing identified 131 miRNAs that were significantly altered between the diabetic and control groups, as well as 141 miRNAs between the prediabetic and control groups (FDR <0.05), with 56 overlapping between contrasts. Fourteen miRNAs in the pre-diabetic group and twelve in the diabetic group overlapped with literature-supported candidates, reinforcing their clinical relevance. In the direct diabetes vs. prediabetes comparison, no miRNAs passed FDR. Still, consistent trend-level decreases in diabetes were observed for hsa-miR-4776-5p, hsa-miR-6778-3p, and hsa-miR-5002-3p, which were among the most upregulated in prediabetes vs. controls.

Sex-stratified analyses revealed distinct miRNA expression patterns, emphasizing the influence of biological sex on miRNA regulation in glucose metabolism. Correlation analyses highlighted miRNAs associated with glucose/HbA1c, alongside relationships among vitamin D status, glycemia, and platelet function.

Source: Results
Authors’ abstract

Introduction

Circulating microRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and play key roles in metabolic diseases, including diabetes. This study aimed to identify circulating miRNA signatures linked to glycemic status, vitamin D deficiency, aspirin consumption, and platelet activity in individuals with type 2 diabetes, prediabetes, and healthy controls.

Methods

Plasma samples from 24 participants (14 with diabetes, 2 prediabetic, and 8 non-diabetic controls) were analyzed using next-generation sequencing to assess differences in miRNA expression.

Results

Although principal component analysis showed no group separation, pairwise testing identified 131 miRNAs that were significantly altered between the diabetic and control groups, as well as 141 miRNAs between the prediabetic and control groups (FDR <0.05), with 56 overlapping between contrasts. Fourteen miRNAs in the pre-diabetic group and twelve in the diabetic group overlapped with literature-supported candidates, reinforcing their clinical relevance. In the direct diabetes vs. prediabetes comparison, no miRNAs passed FDR. Still, consistent trend-level decreases in diabetes were observed for hsa-miR-4776-5p, hsa-miR-6778-3p, and hsa-miR-5002-3p, which were among the most upregulated in prediabetes vs. controls.

Sex-stratified analyses revealed distinct miRNA expression patterns, emphasizing the influence of biological sex on miRNA regulation in glucose metabolism. Correlation analyses highlighted miRNAs associated with glucose/HbA1c, alongside relationships among vitamin D status, glycemia, and platelet function.

Discussion

Collectively, these data highlight the exploratory potential of circulating miRNAs as candidate early biomarkers for glycemic dysregulation, providing a foundation for future validation and development of improved diagnostic and preventive strategies for type 2 diabetes.

Publication and source details

Original title: Circulating microRNA signatures as potential biomarkers differentiating diabetic, prediabetic, and healthy individuals

Hanifa J. Abu-Toamih Atamni; Guy Shapira; Rona Ortenberg; Maya Sultan; Orit Twito; Liat Yoseph-Barzilay; Noam Shomron; Gloria Rashid

Frontiers in Endocrinology · 2025

* Correspondence: Gloria Rashid, Gloriar@clalit.org.ilCopyright © 2025 Abu-Toamih Atamni, Shapira, Ortenberg, Sultan, Twito, Yoseph-Barzilay, Shomron and Rashid.2025Abu-Toamih Atamni, Shapira, Ortenberg, Sultan, Twito, Yoseph-Barzilay, Shomron and Rashidhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declare financial support was received for the research and/or publication of this article. This study was supported by the Israel America Foundation, with a donation made in honor of Helen R. Oken and in memory of her husband, Mortimer Louis Oken. G.S. was supported by the Edmond J. Safra Center for Bioinformatics at Tel Aviv University.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:51:39.004484+00:00

DOI: 10.3389/fendo.2025.1699100 · PMC12630337